NEW YORK (GenomeWeb News) – SQI Diagnostics today announced it has signed a deal with Integrated Sciences to exclusively market, sell and distribute SQI's in vitro diagnostic products in Australia.
Terms of the deal were not disclosed.
Based in New South Wales, Australia, Integrated Sciences distributes products to both the diagnostics and life science markets in the region. Michael Gaynor, director of Integrated Sciences, said in a statement that his firm has seen increasing demand for automated multiplexed technologies.
"As modern medicine continues its rapid evolution, working with companies such as SQI supports our commitment to leverage new and innovative laboratory testing solutions in order to enhance our leadership position in the diagnostics field," he said.
Toronto-based SQI said that it remains on the lookout for strategic partners outside of Canada for its IVD diagnostic products. The microarray-based diagnostics firm reported in December that the net loss for its fiscal fourth quarter of 2011 increased by 50 percent.
Earlier that month it launched a restructuring of its operations to focus on the Diagnostics Tools and Services business. The reorganization also resulted in a reduction in its workforce.